As of Tuesday, G1 Therapeutics Inc.’s (NASDAQ:GTHX) stock closed at $2.59, down from $2.65 the previous day. While G1 Therapeutics Inc. has underperformed by -2.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GTHX fell by -67.71%, with highs and lows ranging from $17.49 to $2.55, whereas the simple moving average fell by -67.81% in the last 200 days.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
On January 30, 2023, JP Morgan Upgraded G1 Therapeutics Inc. (NASDAQ: GTHX) to Neutral. A report published by Needham on January 03, 2023, Reiterated its previous ‘Buy’ rating for GTHX. JP Morgan also Downgraded GTHX shares as ‘Underweight’, setting a target price of $19 on the company’s shares in a report dated November 04, 2021. BTIG Research Initiated an Buy rating on October 15, 2021, and assigned a price target of $51. JP Morgan September 30, 2021d its ‘Overweight’ rating to ‘Neutral’ for GTHX, as published in its report on September 30, 2021. ROTH Capital also rated the stock as ‘Buy’.
Analysis of G1 Therapeutics Inc. (GTHX)
Further, the quarter-over-quarter increase in sales is 77.60%, showing a positive trend in the upcoming months.
One of the most important indicators of G1 Therapeutics Inc.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -209.90% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and GTHX is recording 1.29M average volume. On a monthly basis, the volatility of the stock is set at 7.44%, whereas on a weekly basis, it is put at 5.53%, with a loss of -1.89% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.83, showing growth from the present price of $2.59, which can serve as yet another indication of whether GTHX is worth investing in or should be passed over.
How Do You Analyze G1 Therapeutics Inc. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.90%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 51.30% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in GTHX shares?
The recent increase in stakes in GTHX appears to be a result of several institutional investors and hedge funds increasing their positions. Fisher Asset Management LLC’s position in GTHX has decreased by -4.29% in the first quarter. The company now owns 2,809,444 shares of the stock, with a value of $10.17 million, following the sale of -125,888 additional shares during the last quarter. The Vanguard Group, Inc. made another increased to its shares in GTHX during the first quarter, upping its stake by 12.33%. During the last quarter, the company picked up 206,476 additional shares for a total stake of worth $6.81 million, bringing number of shares owned by the company to 1,881,041.
During the first quarter, JPMorgan Investment Management, I added a 6,729 position in GTHX. Millennium Management LLC purchased an additional 0.5 million shares in the last quarter, increasing its holdings by 42.59%, now holding 1.67 million shares worth $6.05 million. At the end of the first quarter, BlackRock Fund Advisors increased its GTHX holdings by 13.57% and now holds 1.19 million GTHX shares valued at $4.31 million with the added 0.14 million shares during the period. GTHX shares are owned by institutional investors to the tune of 51.30% at present.
